Contribution of obstructive sleep apnea to disrupted sleep in a large clinical cohort of patients with suspected obstructive sleep apnea.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
11 07 2023
Historique:
received: 05 09 2022
revised: 23 12 2022
pmc-release: 02 01 2024
medline: 12 7 2023
pubmed: 3 1 2023
entrez: 2 1 2023
Statut: ppublish

Résumé

The response of sleep depth to CPAP in patients with OSA is unpredictable. The odds-ratio-product (ORP) is a continuous index of sleep depth and wake propensity that distinguishes different sleep depths within sleep stages, and different levels of vigilance during stage wake. When expressed as fractions of time spent in different ORP deciles, nine distinctive patterns are found. Only three of these are associated with OSA. We sought to determine whether sleep depth improves on CPAP exclusively in patients with these three ORP patterns. ORP was measured during the diagnostic and therapeutic components of 576 split-night polysomnographic (PSG) studies. ORP architecture in the diagnostic section was classified into one of the nine possible ORP patterns and the changes in sleep architecture were determined on CPAP for each of these patterns. ORP architecture was similarly determined in the first half of 760 full-night diagnostic PSG studies and the changes in the second half were measured to control for differences in sleep architecture between the early and late portions of sleep time in the absence of CPAP. Frequency of the three ORP patterns increased progressively with the apnea-hypopnea index. Sleep depth improved significantly on CPAP only in the three ORP patterns associated with OSA. Changes in CPAP in the other six patterns, or in full diagnostic PSG studies, were insignificant or paradoxical. ORP architecture types can identify patients in whom OSA adversely affects sleep and whose sleep is expected to improve on CPAP therapy.

Identifiants

pubmed: 36591638
pii: 6966959
doi: 10.1093/sleep/zsac321
pmc: PMC10334732
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Arch Intern Med. 2004 Feb 23;164(4):406-18
pubmed: 14980992
Sleep. 2022 May 12;45(5):
pubmed: 35554584
Sleep Med. 2010 Oct;11(9):890-6
pubmed: 20817600
Nat Sci Sleep. 2021 Jul 06;13:1049-1059
pubmed: 34262376
J Am Geriatr Soc. 2000 Feb;48(2):115-23
pubmed: 10682939
Sleep. 2022 Jun 13;45(6):
pubmed: 35272350
Compr Physiol. 2012 Oct;2(4):2541-94
pubmed: 23720258
Sleep. 2011 Jul 01;34(7):859-67
pubmed: 21731135
Sci Total Environ. 2022 Jan 20;805:150191
pubmed: 34818802
Sleep. 2021 Oct 11;44(10):
pubmed: 34156473
Sleep. 2020 Dec 14;43(12):
pubmed: 32729619
Sleep Breath. 2014 Mar;18(1):59-68
pubmed: 23595703
Brain Sci. 2019 Dec 12;9(12):
pubmed: 31842520
J Appl Physiol (1985). 2008 Nov;105(5):1389-405
pubmed: 18787092
J Clin Sleep Med. 2019 Aug 15;15(8):1155-1163
pubmed: 31482838
J Sleep Res. 2001 Sep;10(3):245-51
pubmed: 11696078
Occup Med (Lond). 2021 Dec 24;71(9):439-445
pubmed: 34693974
Sleep Breath. 2009 Aug;13(3):221-6
pubmed: 19067010
J Clin Sleep Med. 2018 Feb 15;14(2):205-213
pubmed: 29351821
Sleep. 2010 Sep;33(9):1159-64
pubmed: 20857861
Sleep. 2015 Apr 01;38(4):641-54
pubmed: 25348125
Sleep Med. 2020 Sep;73:202-207
pubmed: 32858331
Sleep. 2017 Oct 1;40(10):
pubmed: 28958002
Sleep Med. 2004 Jul;5(4):339-43
pubmed: 15222989
JAMA. 2020 Apr 14;323(14):1389-1400
pubmed: 32286648
Sleep. 2013 Apr 01;36(4):573-82
pubmed: 23565003
J Clin Sleep Med. 2020 Mar 15;16(3):389-399
pubmed: 31992415
Am J Respir Crit Care Med. 2019 Aug 15;200(4):493-506
pubmed: 30764637
Sleep Med. 2016 Jul;23:99-108
pubmed: 27288049
Sleep Med Rev. 2013 Aug;17(4):241-54
pubmed: 23419741
Sleep. 2016 May 01;39(5):1037-45
pubmed: 26951399
Sleep. 2018 Jun 1;41(6):
pubmed: 29522193
Sleep Health. 2020 Feb;6(1):71-78
pubmed: 31759934
Sleep Med. 2021 Nov;87:46-55
pubmed: 34509774

Auteurs

Magdy Younes (M)

Sleep Disorders Center, Misericordia Health Center, University of Manitoba, Winnipeg, Canada.
YRT Limited, Winnipeg, Manitoba, Canada.

Bethany Gerardy (B)

YRT Limited, Winnipeg, Manitoba, Canada.

Eleni Giannouli (E)

Sleep Disorders Center, Misericordia Health Center, University of Manitoba, Winnipeg, Canada.

Jill Raneri (J)

Sleep Centre, Foothills Medical Centre, Department of Medicine, University of Calgary, Calgary, AB, Canada.

Najib T Ayas (NT)

Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

Robert Skomro (R)

Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Canada.

R John Kimoff (R)

Respiratory Division, McGill University Health Centre, Respiratory Epidemiology Clinical Research Unit and Meakins-Christie Laboratories, McGill University, Montreal, QC, Canada.

Frederic Series (F)

Unité de Recherche en Pneumologie, Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, Canada.

Patrick J Hanly (PJ)

Sleep Centre, Foothills Medical Centre, Department of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Andrew Beaudin (A)

Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH